معرفی
Finn Olav Levy is a Professor in the Department of Pharmacology at the University of Oslo, affiliated with the Faculty of Medicine. His research focuses on cardiac pharmacology, G-protein coupled receptors (GPCRs), and signaling pathways in cardiovascular diseases. Key areas include the role of natriuretic peptides, adenylyl cyclase, and cAMP/cGMP regulation in heart failure and cardiac contractility. He has contributed extensively to understanding GPCR-G protein interactions, particularly involving 5-HT7 receptors and β-adrenergic signaling.
Levy's work spans translational research, including drug development for cardiovascular disorders and mechanisms underlying heart failure. Over 50 peer-reviewed articles highlight his expertise in signaling molecules, biosensor technology, and pharmacological modulation of cardiac function. Collaborations with institutions globally emphasize his role in advancing cardiac pharmacology and therapeutic interventions.
Publications in British Journal of Pharmacology, Cardiovascular Research, and FASEB Journal underscore his contributions to understanding GPCR dynamics, cGMP signaling, and translational cardiovascular biology. His research bridges basic science and clinical applications, addressing critical gaps in heart failure pathophysiology and therapeutic targets.
